These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32280029)

  • 1. Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics.
    Kocagoncu E; Quinn A; Firouzian A; Cooper E; Greve A; Gunn R; Green G; Woolrich MW; Henson RN; Lovestone S; ; Rowe JB
    Neurobiol Aging; 2020 Aug; 92():141-152. PubMed ID: 32280029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
    Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Networks of tau distribution in Alzheimer's disease.
    Hoenig MC; Bischof GN; Seemiller J; Hammes J; Kukolja J; Onur ÖA; Jessen F; Fliessbach K; Neumaier B; Fink GR; van Eimeren T; Drzezga A
    Brain; 2018 Feb; 141(2):568-581. PubMed ID: 29315361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
    Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
    Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.
    Cho H; Choi JY; Lee SH; Lee JH; Choi YC; Ryu YH; Lee MS; Lyoo CH
    Neurobiol Aging; 2017 May; 53():103-111. PubMed ID: 28254589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.
    Yu M; Engels MMA; Hillebrand A; van Straaten ECW; Gouw AA; Teunissen C; van der Flier WM; Scheltens P; Stam CJ
    Brain; 2017 May; 140(5):1466-1485. PubMed ID: 28334883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
    Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
    Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread distribution of tauopathy in preclinical Alzheimer's disease.
    Schultz SA; Gordon BA; Mishra S; Su Y; Perrin RJ; Cairns NJ; Morris JC; Ances BM; Benzinger TLS
    Neurobiol Aging; 2018 Dec; 72():177-185. PubMed ID: 30292840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease.
    Zhou J; Greicius MD; Gennatas ED; Growdon ME; Jang JY; Rabinovici GD; Kramer JH; Weiner M; Miller BL; Seeley WW
    Brain; 2010 May; 133(Pt 5):1352-67. PubMed ID: 20410145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment.
    Canuet L; Pusil S; López ME; Bajo R; Pineda-Pardo JÁ; Cuesta P; Gálvez G; Gaztelu JM; Lourido D; García-Ribas G; Maestú F
    J Neurosci; 2015 Jul; 35(28):10325-30. PubMed ID: 26180207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease.
    Pereira JB; Janelidze S; Ossenkoppele R; Kvartsberg H; Brinkmalm A; Mattsson-Carlgren N; Stomrud E; Smith R; Zetterberg H; Blennow K; Hansson O
    Brain; 2021 Feb; 144(1):310-324. PubMed ID: 33279949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head to head comparison of [
    Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the disruptions of the neurophysiological organization in Alzheimer's disease: An integrative approach.
    Gutiérrez-de Pablo V; Poza J; Maturana-Candelas A; Rodríguez-González V; Tola-Arribas MÁ; Cano M; Hoshi H; Shigihara Y; Hornero R; Gómez C
    Comput Methods Programs Biomed; 2024 Jun; 250():108197. PubMed ID: 38688139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.
    Sintini I; Graff-Radford J; Jones DT; Botha H; Martin PR; Machulda MM; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Cereb Cortex; 2021 Feb; 31(3):1693-1706. PubMed ID: 33152765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
    Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.